We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Xencor announced XmAb5871 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of IgG4-Related Disease (IgG4-RD)...